EDIT
Editas Medicine, Inc.
+0.17 (+6.46%)2.89USD1.6M成交股數443M市值–本益比(近四季)9.4股價營收比+232.3%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 11.9M+155% | 2.8M-91% | 7.5M+12266% | 3.6M+597% | 4.7M+310% | 30.6M+474% | 61K-98% | 513K-95% | 1.1M | 5.3M | 2.9M | 9.9M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 20.2M | 17.6M | 19.8M | 16.2M | 26.6M | 48.6M | 47.6M | 54.2M | 48.8M | 40.5M | 29.8M | 37.8M |
| 銷售管理費用 | 11.6M | 10.2M | 12.3M | 12.9M | 13.4M | 16.4M | 18.1M | 18.2M | 19.3M | 15.0M | 17.2M | 23.0M |
| 營業利益 | −18.6M-76% | −25.0M-46% | −24.5M-63% | −51.5M-28% | −76.2M+14% | −46.6M-7% | −65.7M+49% | −71.9M+41% | −67.0M | −50.2M | −44.1M | −51.0M |
| 營業利益率 | -156.0% | -883.2% | -325.4% | -1,440.6% | -1,635.1% | -152.2% | -107,649.2% | -14,016.2% | -5,902.3% | -940.1% | -1,527.3% | -517.3% |
| 稅後淨利 | −18.2M-76% | −25.0M-45% | −25.1M-60% | −53.2M-21% | −76.1M+23% | −45.4M+1% | −62.1M+54% | −67.6M+38% | −62.0M | −45.0M | −40.3M | −49.0M |
| 淨利率 | -153.3% | -882.4% | -333.0% | -1,487.8% | -1,633.5% | -148.3% | -101,870.5% | -13,178.8% | -5,458.1% | -843.7% | -1,395.6% | -497.8% |
| 稀釋 EPS | -0.15-84% | -0.26-53% | -0.28-63% | -0.63-23% | -0.92+21% | -0.550% | -0.75+34% | -0.82+15% | -0.76 | -0.55 | -0.56 | -0.71 |
| 稀釋股數 | 119M | 97.9M | 90.1M | 84.4M | 83.1M | 82.3M | 82.5M | 82.3M | 81.9M | 81.6M | 71.4M | 68.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 182M | 124M | 166M | 139M | 139M | 132M | 95.8M | 64.4M | 69.2M | 82.5M | 221M | 129M |
| 應收帳款 | 2.7M | 2.6M | 8.1M | 588K | 510K | 16.3M | 126K | 244K | 245K | 2.4M | 2.3M | 242K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 237M | 149M | 202M | 211M | 264M | 342M | 328M | 385M | 440M | 505M | 542M | 464M |
| 有息負債 | 48.2M | 47.2M | 54.1M | 51.7M | 49.6M | 52.4M | – | – | – | – | – | – |
| 總負債 | 132M | 145M | 188M | 191M | 201M | 207M | 152M | 153M | 146M | 144M | 142M | 147M |
| 股東權益 | 105M | 4.4M | 13.5M | 19.2M | 62.4M | 134M | 176M | 232M | 294M | 360M | 400M | 317M |
| 負債比 | 55.6% | 97.0% | 93.3% | 90.9% | 76.3% | 60.7% | 46.4% | 39.7% | 33.1% | 28.6% | 26.2% | 31.6% |
| 淨現金(現金 − 有息負債) | 134M | 76.5M | 112M | 86.9M | 89.1M | 79.1M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −23.1M | – | – | −47.8M-4% | – | – | – | −49.9M | – | – | −35.8M |
| 資本支出 | – | 92K | – | – | 114K | – | – | – | 1.9M | – | – | 1.8M |
| 自由現金流 | – | −23.2M | – | – | −47.9M-7% | – | – | – | −51.7M | – | – | −37.6M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -817.8% | – | – | -1,028.6% | – | – | – | -4,558.9% | – | – | -381.8% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 40.5M
| Reportable | 40.5M | 100.0% | +25.4% |
|---|
主要客戶2025 年度 · 37.4M
| Customer One | 23.2M | 62.0% | +28.2% |
|---|---|---|---|
| Customer Two | 10.0M | 26.7% | 0.0% |
| Customer Three | 4.2M | 11.2% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 40.5M | +25.4% | −160M | -395.0% | -1.80 | −166M |
| FY2024 | 32.3M | -58.6% | −237M | -733.7% | -2.88 | −219M |
| FY2023 | 78.1M | +296.3% | −153M | -196.1% | -2.02 | −137M |
| FY2022 | 19.7M | -22.8% | −220M | -1,118.3% | -3.21 | −181M |
| FY2021 | 25.5M | -71.8% | −193M | -753.6% | -2.85 | −172M |
| FY2020 | 90.7M | +341.9% | −116M | -127.8% | -1.98 | −187M |
| FY2019 | 20.5M | -35.7% | −134M | -651.4% | -2.68 | −46.8M |
| FY2018 | 31.9M | – | −110M | -344.3% | -2.33 | −50.5M |